SCHEMBL6459176

SCHEMBL6459176

CC(=O)c1ccc(NC(=O)c2ccc(C(C)=O)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.69
▸ RAB9A P51151 8/20 0.69
▸ KMT2A Q03164 5/20 0.69
▸ POLB P06746 3/20 0.69
▸ MAPT P10636 6/20 0.67
▸ LMNA P02545 2/20 0.67
▸ RXFP1 Q9HBX9 2/20 0.67
▸ APOBEC3G Q9HC16 1/20 0.67
▸ KDM4E B2RXH2 1/20 0.67
▸ MAPK1 P28482 1/20 0.67
▸ CACNA1B Q00975 1/20 0.66
▸ APBA1 Q02410 1/20 0.66
▸ SMN1; SMN2 Q16637 6/20 0.64
▸ PKM P14618 2/20 0.64
▸ TP53 P04637 2/20 0.64
▸ ALOX15 P16050 2/20 0.64
▸ MEN1 O00255 2/20 0.63
▸ APEX1 P27695 1/20 0.63
▸ TDP1 Q9NUW8 1/20 0.63
▸ ATM Q13315 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8771885 0.94 KMT2A (0.63) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL13986883 0.94 CACNA1B (0.76) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL4085808 0.92 SNCA (0.64) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL7592024 0.92 KMT2A (0.81) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL8978184 0.92 KMT2A (0.61) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL13719113 0.92 RAB9A (0.85) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL8978050 0.92 KMT2A (0.61) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL5973851 0.91 NPC1 (0.65) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL24426120 0.90 KMT2A (0.65) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL6227123 0.90 PTPN1 (0.73) NPC1RAB9AKMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187409-A1 Inhibitors of RNase P proteins as antibacterial compounds POWERS GORDON D (US) 2005-08-25 — — US disclosed
WO-2005039494-A2 INHIBITORS OF RNASE P PROTEINS AS ANTIBACTERIAL COMPOUNDS MESSAGE PHARMACEUTICALS, INC. (US) 2005-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187409-A1 Inhibitors of RNase P proteins as antibacterial compounds RNASEH1, RNASEL, RNASE1 NPC1 2983/4885RAB9A 2257/4885KMT2A 3525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback